                         SEQUENCE LISTING

<110>  ARSANIS Biosciences GmbH
       Max-Planck-Gesellschaft zur Frderung der Wissenschaften 
       e.V.
 
<120>  ANTI-GALACTAN II MONOCLONAL ANTIBODIES TARGETING KLEBSIELLA 
       PNEUMONIAE

<130>  AR019P

<160>  32    

<170>  PatentIn version 3.5

<210>  1
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  VH

<400>  1
gaagtgcagc tggtggagtc tgggggagac ttggtaaaac ctggggggtc ccttagactc       60

tcctgtgcag tctctggact cactttcagt gacgcctggc tgaactgggt ccgccagtct      120

ccagggaagg ggccggagtg ggttggccgt attgagagca aagcttatgg tgagacaaca      180

cactactctg cacccgtgag aggcagattc accatctcaa gagatgattc aaaaaacacg      240

atgtatctgc aaatgaacag cctgaaaacc gaagacacag ccgtctatta ctgtgccaca      300

gatgcacagt gggggaggtg gggccaggga accctggtca ccgtctcctc ag              352


<210>  2
<211>  364
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  VH

<400>  2
gaggtgcagc tgttggagtc tgggggaggc cttgtacagc caggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagc aactttgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctggaatg ggtctcatct atttttatcg gtgctgctaa cccaagccat      180

gcagactctg tgaggggccg gttcaccatc tccagagatg attccaagaa cacactgtat      240

ctgcaaatga acagcctgag ggccgaagac acggccgtat attactgtgc gaaagatgag      300

ggtggctcca accttgacta ccttgacaac tggggccagg gaaccctggt caccgtctcc      360

tcag                                                                   364


<210>  3
<211>  328
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  VL

<400>  3
gatattgtga tgacccagac tccactctct ctgtccgtca cccctggaca gccggcctcc       60

atctcttgca agtctagtca gagcctccta aatagcgatg gaaagaccaa cttgtattgg      120

tacctgcaga agccaggcca gcctccacaa ctcctgatgt atgaggtttc cagccggttt      180

tctggagtgc ccgatagatt cagtggcagc gggtcaggga cagatttcac actgaaaatc      240

agccgggtgg aggctgagga tgttgggatt tattactgca tgcaggatcc gtggacgttc      300

ggccaaggga ccaaggtgga aatcaaac                                         328


<210>  4
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  VL

<400>  4
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctcttctgta gggccagtca gtatattggc tacaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctgcagtct      240

gaagactttg cactttatta ctgtcagcag tatcataact ggcctccgta cacctttggc      300

caggggacca agctggagat caaac                                            325


<210>  5
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VH

<400>  5

Glu Val Gln Leu Val Glu Ser Gly Gly Asp Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Val Ser Gly Leu Thr Phe Ser Asp Ala 
            20                  25                  30          


Trp Leu Asn Trp Val Arg Gln Ser Pro Gly Lys Gly Pro Glu Trp Val 
        35                  40                  45              


Gly Arg Ile Glu Ser Lys Ala Tyr Gly Glu Thr Thr His Tyr Ser Ala 
    50                  55                  60                  


Pro Val Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr 
65                  70                  75                  80  


Met Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Ala Thr Asp Ala Gln Trp Gly Arg Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  6
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VH

<400>  6

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Phe 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Phe Ile Gly Ala Ala Asn Pro Ser His Ala Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Asp Asp Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Glu Gly Gly Ser Asn Leu Asp Tyr Leu Asp Asn Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  7
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VL

<400>  7

Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Ser Val Thr Pro Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu Asn Ser 
            20                  25                  30          


Asp Gly Lys Thr Asn Leu Tyr Trp Tyr Leu Gln Lys Pro Gly Gln Pro 
        35                  40                  45              


Pro Gln Leu Leu Met Tyr Glu Val Ser Ser Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Ile Tyr Tyr Cys Met Gln Asp 
                85                  90                  95      


Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  8
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VL

<400>  8

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Phe Cys Arg Ala Ser Gln Tyr Ile Gly Tyr Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Leu Tyr Tyr Cys Gln Gln Tyr His Asn Trp Pro Pro 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  9
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  9

Asp Ala Trp Leu Asn 
1               5   


<210>  10
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  10

Arg Ile Glu Ser Lys Ala Tyr Gly Glu Thr Thr His Tyr Ser Ala Pro 
1               5                   10                  15      


Val Arg Gly 
            


<210>  11
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  11

Asp Ala Gln Trp Gly Arg 
1               5       


<210>  12
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  12

Asn Phe Ala Met Ser 
1               5   


<210>  13
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  13

Ser Ile Phe Ile Gly Ala Ala Asn Pro Ser His Ala Asp Ser Val Arg 
1               5                   10                  15      


Gly 
    


<210>  14
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  14

Asp Glu Gly Gly Ser Asn Leu Asp Tyr Leu Asp Asn 
1               5                   10          


<210>  15
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  15

Lys Ser Ser Gln Ser Leu Leu Asn Ser Asp Gly Lys Thr Asn Leu Tyr 
1               5                   10                  15      


<210>  16
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  16

Glu Val Ser Ser Arg Phe Ser 
1               5           


<210>  17
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  17

Met Gln Asp Pro Trp Thr 
1               5       


<210>  18
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  18

Arg Ala Ser Gln Tyr Ile Gly Tyr Asn Leu Ala 
1               5                   10      


<210>  19
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  19

Gly Ala Ser Thr Arg Ala Thr 
1               5           


<210>  20
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  20

Gln Gln Tyr His Asn Trp Pro Pro Tyr Thr 
1               5                   10  


<210>  21
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  21

Gly Leu Thr Phe Ser Asp Ala Trp 
1               5               


<210>  22
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  22

Ile Glu Ser Lys Ala Tyr Gly Glu Thr Thr 
1               5                   10  


<210>  23
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  23

Ala Thr Asp Ala Gln Trp Gly Arg 
1               5               


<210>  24
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  24

Gly Phe Thr Phe Ser Asn Phe Ala 
1               5               


<210>  25
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  25

Ile Phe Ile Gly Ala Ala Asn Pro 
1               5               


<210>  26
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  26

Ala Lys Asp Glu Gly Gly Ser Asn Leu Asp Tyr Leu Asp Asn 
1               5                   10                  


<210>  27
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  27

Gln Ser Leu Leu Asn Ser Asp Gly Lys Thr Asn 
1               5                   10      


<210>  28
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  28

Glu Val Ser 
1           


<210>  29
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  29

Met Gln Asp Pro Trp Thr 
1               5       


<210>  30
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  30

Gln Tyr Ile Gly Tyr Asn 
1               5       


<210>  31
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  31

Gly Ala Ser 
1           


<210>  32
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CDR

<400>  32

Gln Gln Tyr His Asn Trp Pro Pro Tyr Thr 
1               5                   10  


